We provide a perspective on the cost of abstinence incentives for SUD Substance abusers enter treatment with (BL +) or without (BL −) on-going drug use BL − earn twice as much money as BL + due to providing more negative UA's But only in BL + were outcomes improved by participation in the incentive program Costs may be reduced while benefits are retained by offering incentives only to BL +